U.S. Semiconductors Stock News

Savara (SVRA) is back in focus after the company disclosed an exclusive US distribution deal with PANTHERx Rare Pharmacy for MOLBREEVI, tied to a recent FDA Biologics License Application and Priority Review request. See our latest analysis for Savara. The exclusive MOLBREEVI agreement comes after a strong period for Savara, with a 90 day share price return of 67.6% and a 1 year total shareholder return of 94.17%. However, the 30 day share price return of 9.23% suggests some cooling in the...

In early January 2026, Transocean Ltd. reported a new contract for its Deepwater Mykonos rig with bp in Brazil and an extension for the Transocean Enabler in Norway, together adding approximately US$168 million in firm backlog and extending work on the Enabler through September 2027. These awards further build Transocean’s contracted work pipeline, reinforcing the role of long-term offshore projects in supporting its future revenue visibility. Next, we’ll consider how this additional US$168...

If you are wondering whether Shake Shack at around US$99.93 is offering fair value or stretching expectations, you are not alone. The stock has returned 10.4% over the last 7 days and 19.5% over the last 30 days, with a 19.7% return year to date but a 14.5% decline over the last year and a 7.4% decline over 5 years, alongside an 83.7% return over 3 years. Recent coverage has focused on how these mixed time frames have left some investors reassessing what they are willing to pay for a premium...

Why the latest PAPZIMEOS update matters for Precigen (PGEN) Precigen (PGEN) just highlighted rapid commercialization momentum for PAPZIMEOS, the only FDA approved therapy for adults with recurrent respiratory papillomatosis, alongside expanding US payer coverage and a validated European Medicines Agency filing. See our latest analysis for Precigen. The PAPZIMEOS update lands after a mixed stretch of trading, with a 1 day share price return of 5.76% and a 30 day share price return of 15.75%...

Recent analyst actions on Hub Group (HUBG), including an upgrade to Outperform and several target increases, have sharpened investor focus on the company’s intermodal exposure, cash generation, and potential benefits from an industry rail merger. See our latest analysis for Hub Group. The recent run of analyst upgrades comes as momentum in Hub Group’s shares has picked up, with a 30 day share price return of 9.09% and a 90 day share price return of 28.61%. Meanwhile, the 1 year total...

Recent exploration drilling at Hycroft Mining Holding (HYMC) uncovered high grade silver veins at its Nevada project, alongside fresh insider buying, debt elimination, and a very large share price move tied to stronger precious metal prices. See our latest analysis for Hycroft Mining Holding. Those drilling results, insider buying and the debt clean up sit against a powerful run in the shares, with a 30 day share price return of 161.97% and a very large 1 year total shareholder return,...

Karman Holdings (KRMN) has caught investor attention after strong recent share price moves, with the stock last closing at $108.01 and posting double digit returns over the past month and past 3 months. See our latest analysis for Karman Holdings. Those sharp recent moves are on top of a 40.6% year to date share price return. This suggests momentum has been building as investors reassess Karman Holdings' growth potential and risk profile at around $108 per share. If Karman’s fast climb has...

If you are wondering whether Solventum is offering fair value or represents an opportunity on sale right now, this article walks through what the current price might be indicating. The stock most recently closed at US$80.05, with returns of 11.1% over the past year, a 1.3% gain year to date, and declines of 5.0% over 7 days and 2.2% over 30 days. Recent headlines around Solventum have focused on its position within the healthcare sector and investor interest in how the business trades as a...

Earlier in January 2026, Argan, Inc. reported third-quarter fiscal 2026 earnings that exceeded analyst expectations, slightly missed revenue forecasts, and its Board approved a 33% increase in the quarterly cash dividend, while Director Peter W. Getsinger sold 10,595 shares for about US$3.38 million. This combination of stronger earnings and a sharply higher dividend highlights Argan’s emphasis on returning cash to shareholders even as insider ownership shifts. Next, we’ll examine how the...

In recent days, Rivian Automotive reported 2025 production of 42,284 vehicles and deliveries of 42,247, while also initiating a major recall of nearly 20,000 R1S and R1T vehicles in the US to fix an improperly assembled rear toe link at no charge. At the same time, Rivian appointed Greg Revelle as Chief Customer Officer to oversee the entire customer journey, highlighting a push to tighten execution on sales, marketing, and operations amid rising questions about demand and quality. Against...

Earlier this month, Himax Technologies highlighted its WiseEye endpoint AI, automotive display IC portfolio, and Front-lit LCoS microdisplays at CES 2026, while also addressing progress in co-packaged optics collaborations and preparing to discuss its 2025 results at the upcoming Needham Growth Conference and February earnings call. A key development was the new AR glasses optical reference design jointly announced by Vuzix Corporation and Himax, pairing Himax’s ultra-compact HX7319FL...

Why Revolve Group’s new Grove store matters for investors Revolve Group (RVLV) has opened a new permanent store at The Grove in Los Angeles, extending its presence beyond e commerce and into a high visibility, experiential retail setting. The two level space brings the REVOLVE and FWRD concepts under one roof, with apparel, footwear, accessories, beauty, home products, and a growing focus on menswear and pre owned luxury handbags through FWRD Renew. See our latest analysis for Revolve...

If you are trying to figure out whether Centrus Energy's share price makes sense right now, the key question is how that price compares with the underlying value of the business. The stock recently closed at US$307.57, after a 4.8% decline over the last 7 days, a 34.5% gain over 30 days, a 12.9% gain year to date, a 317.8% gain over 1 year and a very large gain across 3 and 5 year periods. Recent news coverage has focused on Centrus Energy's role in the nuclear fuel supply chain and ongoing...

This article examines whether AT&T, trading at around US$23.61, represents a solid value opportunity or a value trap by reviewing what the numbers indicate. The share price has declined 1.5% over the last 7 days, is down 2.9% over 30 days and 3.9% year to date, while the 1-year return is 12.5% and the 3- and 5-year returns are 46.5% and 45.7% respectively. Recent coverage of AT&T has focused on its position in the US telecom sector and ongoing investor interest in established dividend...

Why Strive Asset Management (ASST) Is On Investors’ Radar Strive Asset Management (ASST) has drawn attention after recent share performance data highlighted a one-month return of 30.51% and a past three-month return of 14.44%, alongside revenue of US$5.51m and a net loss of US$223.39m. See our latest analysis for Strive Asset Management. The recent 30-day share price return of 30.51% and year to date share price return of 19.13%, with the stock now at US$1.03, suggest that momentum has picked...

If you are wondering whether General Mills shares offer fair value at today's price, this article will walk through what the current numbers may be telling you about the stock. The share price last closed at US$45.62, with a 6.2% gain over the past 7 days, while returns sit at a 3.1% decline over 30 days and a 17.8% decline over 1 year. This may signal that expectations and risk perceptions have been shifting. These moves come as investors continue to reassess large packaged food companies,...

If you are wondering whether Stoke Therapeutics at around US$30.97 is still offering value or already pricing in a lot of optimism, you are not alone. The stock has seen a 226.3% return over the last year, although the past 7 days and 30 days brought declines of 11.9% and 6.1% respectively, and year to date it is close to flat at 0.2%. Recent attention on Stoke Therapeutics has centered on its position in the pharmaceuticals and biotech space, where investors often react quickly to clinical...

Bitmine Immersion Technologies (BMNR) has opened Q1 2026 with revenue of US$2.3 million and Basic EPS of a US$15.98 loss, while trailing 12 month figures show revenue of US$7.2 million and Basic EPS of a US$46.42 loss. Over the past year, revenue has moved from US$3.3 million in Q4 2024 to US$6.1 million on a trailing 12 month basis in Q4 2025, alongside a shift in Basic EPS from a US$1.32 loss to US$13.60. With the latest quarter firmly in loss making territory, the focus now is on how...

If you are wondering whether Kraft Heinz at US$24.32 is pricing in too much caution or too little optimism, you are not alone. The stock has gained 3.8% over the last 7 days, while the 30 day return is a 1.5% decline and the return over the last year is an 11.0% decline, which may signal changing views on its potential and risk. Recent coverage has focused on Kraft Heinz as a key packaged food name in a market where investors are weighing defensiveness against growth. Many commentators are...

If you are wondering whether S&P Global's share price still makes sense at current levels, this article walks through what the numbers say about its valuation and what that could mean for your portfolio. The stock last closed at US$545.00, with returns of 1.4% over 7 days, 9.1% over 30 days, 6.3% year to date, 10.6% over 1 year, 53.4% over 3 years and 76.5% over 5 years. This naturally raises questions about how much of this performance is already reflected in the price. Recent attention on...

If you are wondering whether Federal Home Loan Mortgage at US$9.18 is still good value after its run in recent years, you are not alone. The stock has seen a 62.2% return over the last year, even though the 7 day, 30 day and year to date returns of 9.6%, 9.9% and 11.3% declines suggest some recent cooling. Recent news coverage has focused on Federal Home Loan Mortgage's role in the broader US housing finance system and the ongoing investor interest in government sponsored entities. This...

If you are asking yourself whether Dynatrace shares offer good value at around US$39.98, you are not alone. Many investors are rethinking what a fair price looks like for this stock. The share price has recently moved lower, with a 7 day return of an 8.8% decline, a 30 day return of a 9.9% decline, and a year to date return of a 5.6% decline, while the 1 year return sits at a 20.9% decline and the 3 year return at 7.4%. These moves are happening alongside ongoing interest in software names...

National Energy Services Reunited Corp. recently presented at the Goldman Sachs Energy, CleanTech & Utilities Conference in Florida and the Future Minerals Forum 2026 in Riyadh, highlighting its role in Middle East and North Africa oilfield services and related technologies. These appearances come shortly after NESR secured a large unconventional fracturing contract tied to agreements worth over US$30.00 billion, which analysts describe as potentially transformational for the company’s...

Planet Fitness recently reported its 2025 operational results, with membership reaching about 20.8 million, 181 new clubs opened, and system‑wide same‑club sales rising 6.7% to end the year with 2,896 locations. This combination of growing member numbers, new franchised and corporate sites, and improving same‑club performance highlights how the model is scaling across the network. Next, we’ll examine how this membership growth and accelerated club expansion could influence Planet Fitness’s...